Use Options For a Chance To Buy ITCI at a 46% Discount

Looking back to 125 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 4,750,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 35.1% higher than the offering price..